07:11 AM EDT, 03/16/2026 (MT Newswires) -- Acumen Pharmaceuticals ( ABOS ) said Monday that it will raise about $35.75 million through a private placement, with each share priced at $3.30.

The company said it signed a securities purchase agreement with certain investors led by RA Capital Management, with participation from ADAR1 Capital Management, Sands Capital, and a large investment management company.

Proceeds from the offering, expected to close Monday, will primarily fund its Enhanced Brain Delivery program, including ongoing preclinical work to nominate a lead clinical candidate, with an investigational new drug submission targeted for mid-2027, Acumen said.

Shares of the company were up more than 8% in premarket activity Monday.